Hiroki Sugita is a partner in Orrick’s Tokyo Office and a member of the M&A and Private Equity Group. He works on a wide range of cross-border transactions including mergers and acquisitions, joint ventures, emerging companies and venture capital transactions, and private equity investment especially in Japan, the United States, Europe and Asia.

He also has extensive experience in fund formation, real estate and various types of finance transactions.

Hiroki has a deep understanding of clients’ needs from his secondment experience with a U.S. investment bank in 2005 and a Japanese major trading house from 2012 to 2014.

Prior to joining Orrick, Hiroki worked at O’Melveny’s Tokyo office as a counsel where he mainly worked on cross border M&A.

He is recommended in various publications and rankings including Corporate and M&A in The Legal 500 Asia Pacific (2015).

  • Hiroki's representative experience includes the following:

    Mergers and Acquisitions (Cross-border)

    • Representation of a Japanese chemical manufacturer in the acquisition of a German insulation systems manufacturer
    • Representation of a leading U.S. manufacturer of high performance semiconductors in acquisition of high performance filter business from Panasonic Corporation through corporate separation.
    • Representation of a leading U.S. manufacturer and supplier of electronic components, in acquisition of a Japanese electronic parts company.
    • Representation of a major Japanese trading firm in investment in an Indonesia base high speed network company.
    • Representation of a Japanese information and communication technology service provider and a Japanese trading firm in investment in an Indonesia-based data center company.
    • Representation of a leading hard drive manufacturer in its $4.8B acquisition of a Japanese hard disk drive manufacturer.
    • Representation of a Japan based online game company in its acquisition of various online game contents companies.
    • Representation of a global food and beverage producer based in Japan in its acquisition of allergy oriented, hypoallergenic nutritional supplement company through a public tender offer.
    • Representation of a Japan based electronic and electronics equipment manufacturer in its acquisition of a Japan subsidiary of U.S. based electronic and electrical interconnect system supplier.

    Private Equity and Venture Capital (Cross-border)

    • Representation of a Japanese trading firm in investment in a China-based drug research and development company.
    • Representation of a Japanese trading firm in investment in a China-based energy storage company.
    • Representation of a Japanese trading firm in its investment in a Chinese fund
    • Representation of Coller Capital in its investment in a Pfizer Japan’s spin-off company through subscription of shares and warrants
    • Representation of foreign sovereign fund in its investment in a licensed securities company through convertible preferred stock subscription.

Insights

News